重症监护病房中婴儿和儿童的肾脏替代治疗。
Renal replacement therapies for infants and children in the ICU.
机构信息
Department of Medicine-Nephrology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Division of Pediatric Nephrology, Stead Family Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA.
出版信息
Curr Opin Pediatr. 2020 Jun;32(3):360-366. doi: 10.1097/MOP.0000000000000894.
PURPOSE OF REVIEW
Pediatric acute kidney injury (AKI) in critically ill patients is associated with increased morbidity and mortality. Emerging data support that the incidence of pediatric AKI in the ICU is rising. For children with severe AKI, renal replacement therapy (RRT) can provide a lifesaving supportive therapy. The optimal timing to deliver and modality by which to deliver RRT remain a point of discussion within pediatric (and adult) literature. This review discusses the use of RRT for pediatric patients in the ICU. We discuss the most recent evidence-based methods for RRT with a focus on continuous RRT.
RECENT FINDINGS
The feasibility of dialyzing the smallest infants and more medically complex children in the ICU is dependent on the advancements in dialysis access and circuit technology. At present, data indicate that upward of 27% of children in the ICU develop AKI and 6% require RRT. Newer dialysis modalities including prolonged intermittent hemodialysis and continuous flow peritoneal dialysis as well as newer dialysis technologies such as the smaller volume circuits (e.g., Cardio-Renal Pediatric Dialysis Emergency Machine, Newcastle Infant Dialysis and Ultrafiltration System) have made the provision of dialysis safer and more effective for pediatric patients of a variety of sizes.
SUMMARY
Renal replacement in the ICU requires a multidisciplinary team approach that is facilitated by a pediatric nephrologist in conjunction with intensivists and skilled nursing staff. Although mortality rates for children on dialysis remain high, outcomes are improving with the support of the multidisciplinary team and dialysis technology advancements.
目的综述
危重症患儿急性肾损伤(AKI)与发病率和死亡率增加相关。新出现的数据支持 ICU 中儿童 AKI 的发病率正在上升。对于严重 AKI 的儿童,肾脏替代治疗(RRT)可以提供救命的支持性治疗。在儿科(和成人)文献中,关于提供 RRT 的最佳时机和方式仍存在争议。这篇综述讨论了 ICU 中儿科患者的 RRT 应用。我们讨论了基于最新循证的 RRT 方法,重点是连续 RRT。
最近的发现
在 ICU 中对最小的婴儿和更复杂的儿童进行透析的可行性取决于透析通路和回路技术的进步。目前,数据表明,多达 27%的 ICU 患儿发生 AKI,6%需要 RRT。新的透析方式包括延长间歇性血液透析和连续流动腹膜透析,以及更小体积回路等新的透析技术(例如,Cardio-Renal Pediatric Dialysis Emergency Machine、Newcastle Infant Dialysis 和 Ultrafiltration System)使儿科患者的透析更安全、更有效,各种体型的儿童都适用。
总结
ICU 中的肾脏替代治疗需要多学科团队方法,儿科肾脏病专家与重症监护医生和熟练护理人员共同协作。尽管接受透析的儿童死亡率仍然很高,但在多学科团队和透析技术进步的支持下,预后正在改善。